Comparison Study of Topical Acne Regimens

Inclusion Criteria: * Subjects and/or subjects' legal guardians who understand and are willing to sign an Informed Consent Form, an Assent Form if indicated, and a HIPAA Authorization Form. * Subjects who have received the permission of a parent or guardian to participate in this study or cannot be classified as a minor, under the age of 18 years. * Male and female subjects between the ages of 13 and 45 years and in generally good health, as determined by a Medical History Form. * Subjects with moderately-severe acne vulgaris of the face and neck as determined and defined by baseline lesion counts (see Definition: Acne Severity above). * Subjects who have completed a Medical History Form. * Subjects who have not used oral acne medications for 1 month prior to start of study, and topical acne medications 1 week prior to start of study. * Subjects who agree not to use any acne medication during the study except for the test materials given to them. * Subjects who agree not to use any make-up that contains acne treatment additives, such as benzoyl peroxide, salicylic acid or retinol. * Subjects who are willing to be photographed and video-recorded during study visits and willing to sign photographic release forms. * Subjects who exhibit dependability and intelligence in following directions. Exclusion Criteria: * Subjects who are pregnant or lactating. * Subjects with known allergies to cosmetic, toiletry, or acne treatment products. * Subjects who are sensitive to any of the ingredients in the test articles. * Subjects who have participated in a facial treatment study within 3 weeks of study initiation. * Subjects exhibiting acute or chronic dermatological, medical, and/or physical conditions which would preclude application of the test materials and/or influence the outcome of the study. * Subjects who are unable to sit quietly for 15 minutes to acclimate to ambient temperature and humidity conditions in the laboratory. * Male subjects who do not have a full beard. * Subjects who cannot stop usage of oral acne mediation 1 month prior to study start, and topical acne medications 1 week prior to study start. * Subjects taking routine high dosage anti-inflammatory medications (aspirin, ibuprofen). * Subjects who must use oral corticosteroids and/or oral immunosuppressive drugs (steroid inhalers or decongestant nose drops and/or eye drops are permitted). * Any condition for which the Investigator determines that the subject could be placed under undo risk.